Aprea Therapeutics, Inc. (APRE)

Change in Working Capital

$206.56K

Quarterly · Period ending: · USD

APRE logo

APRE Change in Working Capital

Latest reported$206.56K
APRE Quarterly Change in Working Capital (-$303.46K → $206.56K)
High-resolution chart · PNG

APRE change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
206,555
432,406
-667,866
-323,694
-63,165
125,630
-708,376
1,125,454
-310,863
-1,161,611
-462,863
882,207
-170,991
1,370,358
-1,666,936
-2,643,216
2,121,825
429,748
-4,510,518
-908,994
322,552
-3,229,934
-468,882
-260,587
3,535,208
3,133,278
442,404
503,455
126,777
87,903
966,765
-303,459
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.